N+1 Singer restated their buy rating on shares of Udg Healthcare PLC (LON:UDG) in a research note issued to investors on Thursday morning. The brokerage currently has a GBX 746 ($9.25) target price on the stock.

Other analysts have also issued research reports about the stock. Numis Securities Ltd restated an add rating and issued a GBX 675 ($8.37) target price on shares of Udg Healthcare PLC in a research report on Thursday, August 4th. Goodbody restated a buy rating on shares of Udg Healthcare PLC in a research report on Thursday, November 24th. Berenberg Bank raised their target price on shares of Udg Healthcare PLC from GBX 700 ($8.68) to GBX 720 ($8.93) and gave the company a buy rating in a research report on Friday, November 18th. Liberum Capital started coverage on shares of Udg Healthcare PLC in a research report on Thursday, October 27th. They issued a buy rating and a GBX 750 ($9.30) target price on the stock. Finally, Jefferies Group raised their target price on shares of Udg Healthcare PLC from GBX 680 ($8.44) to GBX 720 ($8.93) and gave the company a buy rating in a research report on Friday, September 30th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of Buy and a consensus target price of GBX 714.33 ($8.86).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Udg Healthcare PLC (LON:UDG) opened at 649.00 on Thursday. The company has a 50-day moving average of GBX 653.65 and a 200-day moving average of GBX 615.91. Udg Healthcare PLC has a 52 week low of GBX 491.30 and a 52 week high of GBX 692.50. The firm’s market capitalization is GBX 1.60 billion.

ILLEGAL ACTIVITY NOTICE: This news story was published by Financial Market News and is the propert of of Financial Market News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The original version of this news story can be viewed at http://www.financial-market-news.com/udg-healthcare-plc-udg-stock-rating-reaffirmed-by-n1-singer/1209718/.

In related news, insider Chris Corbin sold 90,849 shares of the business’s stock in a transaction on Monday, September 26th. The shares were sold at an average price of GBX 634 ($7.87), for a total value of £575,982.66 ($714,530.03).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.